» Articles » PMID: 30763250

Detection and Control of Unannounced Exercise in the Artificial Pancreas Without Additional Physiological Signals

Overview
Date 2019 Feb 15
PMID 30763250
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to develop an algorithm that detects aerobic exercise and triggers disturbance rejection actions to prevent exercise-induced hypoglycemia. This approach can provide a solution to poor glycemic control during and after aerobic exercise, a major hindrance in the participation of exercise by patients with type 1 diabetes. This novel exercise-induced hypoglycemia reduction algorithm (EHRA) detects exercise using a threshold on a disturbance term, a parameter estimated from an augmented minimal model using an unscented Kalman filter. After detection, the EHRA triggers the following three actions: First, a carbohydrate suggestion, second, a reduction in basal insulin and the insulin-on-board maximum limit, and finally, a 30% reduction of the next insulin meal bolus. The EHRA was tested in silico using a 15-day scenario with 8 exercise sessions of 50 min at [Formula: see text] on alternating days. The EHRA was able to obtain improved results when compared to strategies with and without exercise announcement. The unannounced, announced, and EHRA strategies all obtained an overall percentage of time in range (70-180 mg/dl) of 94% and a percentage of time 70 mg/dl of 2%, 0%, and 0%, respectively. The EHRA was tested for robustness during exercise sessions of +25% and -25% intensity and results suggest that the EHRA is able to account for variability in exercise intensity, duration, and patient dynamics such as glucose uptake rate and insulin sensitivity.

Citing Articles

Design of a Real-Time Physical Activity Detection and Classification Framework for Individuals With Type 1 Diabetes.

Cho S, Aiello E, Ozaslan B, Riddell M, Calhoun P, Gal R J Diabetes Sci Technol. 2023; 18(5):1146-1156.

PMID: 36799284 PMC: 11418461. DOI: 10.1177/19322968231153896.


A Hybrid Automata Approach for Monitoring the Patient in the Loop in Artificial Pancreas Systems.

Beneyto A, Puig V, Bequette B, Vehi J Sensors (Basel). 2021; 21(21).

PMID: 34770425 PMC: 8587755. DOI: 10.3390/s21217117.


Fault Tolerant Strategies for Automated Insulin Delivery Considering the Human Component: Current and Future Perspectives.

Beneyto A, Bequette B, Vehi J J Diabetes Sci Technol. 2021; 15(6):1224-1231.

PMID: 34286613 PMC: 8655284. DOI: 10.1177/19322968211029297.


Artificial Intelligence in Decision Support Systems for Type 1 Diabetes.

Tyler N, Jacobs P Sensors (Basel). 2020; 20(11).

PMID: 32517068 PMC: 7308977. DOI: 10.3390/s20113214.


Closed-loop bioelectronic medicine for diabetes management.

Guemes Gonzalez A, Etienne-Cummings R, Georgiou P Bioelectron Med. 2020; 6:11.

PMID: 32467827 PMC: 7227365. DOI: 10.1186/s42234-020-00046-4.